We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Groundbreaking System Combining Leadless Pacemaker with Subcutaneous Defibrillator to Revolutionize Cardiac Care

By HospiMedica International staff writers
Posted on 02 Jul 2024

A major complication with traditional pacemakers and defibrillators is the risk of infection, which may require the removal of the leads—insulated wires that convey electrical impulses to the heart. More...

Additionally, these leads are susceptible to breaking, requiring their removal. Extracting leads is a complex procedure that requires specialized equipment and poses increasing risks the longer the leads are embedded in the body and the more they become integrated with heart tissue and blood vessels. Now, a new system described in an article published in the New England Journal of Medicine, marks a significant advancement in cardiac care and promises safer and more effective treatment for patients.

This groundbreaking system, developed through an international study involving dozens of researchers worldwide, including from the University of Tennessee Health Science Center (Memphis, TN, USA), combines an atrial leadless pacemaker with a novel subcutaneous defibrillator. The new devices aim to eliminate the hazardous complications associated with conventional devices by doing away with the need for lead extraction. The subcutaneous defibrillator is implanted on the left side of the body near the ribcage, with the wire routed subcutaneously and positioned above the sternum, ensuring no contact with the blood pool. Conversely, the leadless pacemaker, roughly the size of an AA battery, is implanted in the leg, led through the femoral vein and attached to the inside of the heart. These two devices communicate wirelessly to correct dangerous cardiac arrhythmias without the need for direct electrical shocks to the heart.

“When the leadless pacemaker sees a dangerous heart rhythm, it can appropriately respond to that event, it can perform antitachycardia pacing, and it can respond back to the defibrillator that it was doing that, so the defibrillator doesn’t shock the patient,” said Harish Manyam, MD, interim chair of the Department of Medicine at the University of Tennessee Health Science Center’s College of Medicine, who was part of the international study that involved dozens of researchers worldwide. “If that doesn’t work, the pacemaker will let the defibrillator know, and the defibrillator itself will shock the patient.”

Related Links:
University of Tennessee Health Science Center


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Dual Chamber Warming Cabinet
D-Series
New
Infusion System
SIGMA Spectrum
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.